OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells remains a paramount challenge for the biopharmaceutical industry. A variety of strategies can be employed to antibody titer, including process parameter optimization, cell line development, and implementation of perfusion systems. Fine-tuning growth parameter